Search

everythinglearnresearchcommunity

for

Search:↓

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

Environmental factors at different levels control hair stem cell activity, which could lead to new hair growth and alopecia treatments.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

The document explains hair growth and shedding, factors affecting it, and methods to evaluate hair loss, emphasizing the importance of skin biopsy for diagnosis.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

Trichoscopy helps diagnose and assess the severity of Frontal Fibrosing Alopecia.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Treatments for Frontal Fibrosing Alopecia have not been proven effective.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

The document concludes that correct diagnosis of alopecia types is crucial, scalp biopsies are important, and more research is needed.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

Hodgkin's lymphoma can show up as hair loss.

Patients with severe alopecia areata have higher levels of MIF, which decrease after successful treatment.

Some women with Frontal Fibrosing Alopecia also have Lichen Planopilaris, which can lead to more symptoms and affect hair outside the scalp.

A mother and daughter with similar hair loss conditions and identical HLA types suggest a genetic link between the conditions.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

Interleukin-2 treatment improved hair growth, sexual function, and reduced fungal infection in a patient with thymoma-related symptoms.

Chemotherapy may cause recurring hair loss due to an autoimmune response.

The report suggests that hair loss in Cronkhite-Canada syndrome may be caused by alopecia areata incognita, as shown by a patient's improvement with treatment.

A man lost all his hair after stopping hepatitis C treatment and it didn't grow back.

Scalp tourniquets did not significantly prevent hair loss from chemotherapy.

A new gene variant in the DSP gene is linked to a unique type of hair loss.

A rare case showed hair regrowth after chemotherapy for thymoma, suggesting a link between alopecia areata and thymoma.

A boy's hair loss improved after tumor removal and vitamin D treatment, but hair loss returned despite normal vitamin D and no tumor regrowth.

A woman's hair loss condition got worse after her varicose vein treatment with a specific foam.

A woman's hair grew back while she was taking sulphasalazine for arthritis.

Alopecia areata causes hair loss with varied treatment responses and frequent relapses.